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Abstract: Background: Abnormal glucose tolerance (AGT) in non-diabetic patients with acute myocardial infarction is 
associated with decreased survival compared to those with normal glucose tolerance (NGT). The aim of this study was to 
test if two-hour postprandial glucose (PPG2h) after a mixed meal correlates with the two-hour oral glucose tolerance test 
(OGTT2h). 
Methods: We prospectively enrolled 189 non-diabetic patients with acute myocardial infarction. 
Results: According to the oral glucose tolerance test (OGTT), 37.0% had NGT, 4.8% had impaired fasting glucose, 37.6% 
had impaired glucose tolerance (IGT) and 20.6% had diabetes. PPG2h after each meal correlated with OGTT2h (R2= 
0.13-0.26, P<0.001). In diabetic patients, PPG2h levels after each meal were higher (p<0.01 for all) than in the IGT and 
NGT group. In the NGT and IGT group, PPG2h was higher after lunch and dinner than after breakfast (p<0.01), but this 
was not the case in the diabetic patients. In detecting diabetes compared to OGTT2h, PPG2h equal to or above 5.6 mmol/l 
after breakfast, 6.5 mmol/l after lunch and 7.0 mmol/l after dinner had a sensitivity of at least 76% and specificity of at 
least 42%. Glucose values below the cut-off values suggest that OGTT need not be evaluated. 
Conclusion: PPG2h is a quick, practical, simple and easy measurement in clinical practice. PPG2h correlates with OGTT 
but the value is lower, so PPG2h cannot be used to evaluate postprandial glycemia with the current OGTT glycemic 
thresholds. We therefore suggest the use of new cut-off values for PPG2h after a random meal to select patients in whom 
OGTT is not needed to evaluate diabetic status. 
Keywords: Abnormal glucose tolerance, acute myocardial infarction, impaired glucose tolerance, newly diagnosed diabetes, 
oral glucose tolerance test, postprandial glucose, stress-induced hyperglycemia. 
INTRODUCTION 
 Physiological variation of plasma glucose is tightly 
controlled after either prolonged fasting or a meal; it is generally 
between 4 and 7 mmol/l in humans. Glycosylated hemoglobin 
A1c (HbA1c) provides a method for approximating plasma 
glucose concentration during the previous 2 to 3 months [1,2]. 
HbA1c measurements are the mainstay of monitoring long-term 
glycemic control in patients with diabetes mellitus. Fasting 
plasma glucose (FPG) and two-hour oral glucose tolerance test 
(OGTT2h) levels correlate significantly with HbA1c within its 
reference range. However, OGTT2h is a more sensitive 
indicator of abnormal glucose tolerance (AGT) than either FPG 
or HbA1c [2]. The development of type 2 diabetes progresses 
from normal glucose homeostasis to postprandial hyper-
glycemia and only then to fasting hyperglycemia [3]. 
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 Insulin secretion was first demonstrated to be biphasic 
over 40 years ago [4]. After a hyperglycemic stimulus, 
insulin concentration in plasma rises rapidly within minutes, 
corresponding to first-phase insulin secretion, and decreases 
after 10-15 minutes. The gradual rise in plasma insulin 
concentrations that represent the second-phase secretion can 
be measured in the 2-3-hour period after glucose intake [4]. 
Type 2 diabetes is a polygenic disorder in which 
environmental or acquired factors modulate the risk and 
phenotype of the disease. Both hereditary and modulating 
factors can affect beta-cell function and insulin sensitivity 
[4]. First-degree relatives of type 2 diabetes have reductions 
in first- and second-phase insulin release while having no 
change in insulin sensitivity [4,5]. Thus, impaired first-phase 
insulin secretion and the resulting postprandial 
hyperglycemia is a primary defect for impaired glucose 
tolerance (IGT) and type 2 diabetes. Several mechanisms 
might explain perturbations of the biphasic insulin secretion 
in a pathological situation [6]. Reduced first-phase insulin 
secretion is responsible for the impaired inhibition of hepatic 
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glucose output postprandially in IGT and type 2 diabetes. 
Together with diminished peripheral glucose uptake, these 
perturbations contribute to postprandial hyperglycemia [5]. 
 The worldwide epidemic of type 2 diabetes and its 
complications is a growing problem. According to large 
cohort studies, patients with diabetes or pre-diabetic 
conditions are at higher risk for cardiovascular events than 
those with normal glucose tolerance (NGT) [1,7]. Diabetic 
patients and also newly-detected diabetes or IGT patients are 
also at a high risk for death and cardiovascular events after 
acute myocardial infarction [8-10]. Furthermore, there is 
evidence that postchallenge glucose is associated with 
adverse cardiovascular outcomes and death in both the 
diabetic and non-diabetic populations [1,7,11-13]. Thus, 
most epidemiological data implicate postprandial 
hyperglycemia in the development of cardiovascular 
diseases, while the link between fasting glycemia and 
diabetic complications is inconclusive [14]. Cavalot et al. 
[11] found that postprandial glucose (PPG) predicted 
cardiovascular events better than fasting plasma glucose 
(FPG) in patients with type 2 diabetes, especially in women. 
The European Society of Cardiology and the European 
Association for the Study of Diabetes recommend that an 
oral glucose tolerance test (OGTT) is indicated if HbA1c 
and/or FPG are inconclusive in patients with cardiovascular 
disease [15]. 
 FPG is more practical than OGTT for evaluating 
cardiovascular risk. However, AGT defined by OGTT is 
better for determining cardiovascular prognosis after 
myocardial infarction [8]. OGTT is a non-physiological test 
of glucose absorption that classifies patients by their 
metabolic characteristics. Normally, people eat two to four 
major mixed meals per day with a varying carbohydrate, 
protein and fat content. Thus, glycemic excursion after a 
meal is lower than after OGTT [16]. The everyday picture is 
thus better reflected by PPG2h than OGTT2h. A standard 
mixed meal may not always be applicable, and it is not 
known whether a random PPG2h can be used to estimate a 
standardized OGTT2h result. 
 In the Diabetes Intervention Study (DIS), PPG was an 
independent risk factor for death in patients with type 2 
diabetes [13], while in the STOP-NIDDM Study [12], 
decreasing PPG with acarbose was associated with a lower 
incidence of cardiovascular events in patients with IGT. By 
contrast, the HEART2D Study [17] found no difference in 
future cardiovascular event rates after myocardial infarction 
between prandial strategy groups and basal strategy groups 
in diabetic patients, while the difference of PPG between the 
groups was negligible. 
 The aim of this study was to evaluate PPG2h compared 
to OGTT2h in patients with acute myocardial infarction 
without known diabetes. 
MATERIALS AND METHODS 
Subjects 
 Patients with confirmed myocardial infarction [18,19] 
and without known diabetes or receiving antihyperglycemic 
treatment were enrolled between September 2006 and July 
2008 at Tampere University Hospital and Seinäjoki Central 
Hospital. The final cohort consisted of 189 out of 229 
enrolled patients (Fig. 1). Patient demographics are given in 
(Fig. 1). All coronary interventions were performed at 
Tampere University Hospital. 
 Inclusion criteria were a verified acute myocardial 
infarction, an age between 18 and 90 years, plasma glucose < 
11.1 mmol/l (divide by 0.05551 to get mg/dl) at admission, 
and an ability and allowance to eat regular food containing 
carbohydrates. Myocardial infarction was diagnosed in cases 
of two measurements of an elevated serum troponin T 
concentration (>0.03 µg/l) and either typical symptoms of 
myocardial ischemia (chest pain lasting >15 minutes, or 
pulmonary edema in the absence of cardiac valvular disease, 
or cardiogenic shock, or ventricular tachycardia or 
fibrillation) or electrocardiogram changes (ST changes, new 
left bundle branch block, or new pathologic Q waves) 
[18,19]. Patients with previously diagnosed diabetes or 
receiving antihyperglycemic treatment, and/or renal 
insufficiency treated with dialysis were excluded. 
Demographic and clinical information was collected during 
the hospital stays. 
 Hypertension was recorded if treated prior to enrollment. 
Smoking history was recorded if the patient smoked or had 
smoked regularly. Previous myocardial infarction was 
recorded if previously treated or diagnosed. Atherosclerotic 
disease was recorded if treated surgically or percutaneously, 
or if a patient had typical symptoms (for example 
claudication). Family history was recorded if there was 
cardiovascular disease in the family at a young age (under 
50). Stroke was recorded if previously diagnosed. 
 The glucometabolic state was classified based on the 
World Health Organization criteria [16] for plasma glucose. 
NGT was recognized as FPG <6.1 mmol/l and OGTT2h 
glucose <7.8 mmol/l, impaired fasting glucose as fasting 
glucose 6.1-6.9 mmol/l and OGTT2h glucose < 7.8mmol/l, 
IGT as FPG <7.0 mmol/l and OGTT2h glucose 7.8-11.0 
mmol/l, and diabetes as FPG ≥7.0 mmol/l or OGTT2h 
glucose ≥11.1 mmol/l. Patients were classified as having 
AGT when FPG was ≥6.1 mmol/l or OGTT2h ≥7.8 mmol/l. 
 Waist circumference was defined as centimeters above 
risk limit (women >88 cm (>35”) and men >102 cm (>40”)). 
 All patients received standard cardiac care. Angiography 
was performed on all but 18 patients who had either 
contraindication for antithrombotic therapy or whose 
symptoms stabilized with conservative care. Fifteen out of 
171 angiographed patients were not revascularized because 
of clinically negligible coronary stenoses. 
Biochemical Analyses 
 Admission plasma glucose was measured with Lifescan 
One Touch® Ultra® 2. HbA1c was analyzed immuno-
chemically (normal range 4.0-6.5%, Tina Quant®, Roche, 
Basel, Switzerland). Venous blood was drawn during OGTT 
(at 0 and 120 min). PPG plasma glucose was measured 120 
min after breakfast, lunch and dinner with an ARKRAY 
Glucocard X-meter GT-1910®. 
 The patients’ glucometabolic states were evaluated with 
OGTT not earlier than 24 hours after admission to hospital, 
and PPG2h was measured two hours after breakfast, lunch 
and dinner. OGTT (75g glucose in 330ml water; Glukodyn®) 
and PPG measurements were performed on the ward during 
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stable conditions before discharge. Mean hospital diet 
content was calculated from the daily content of meals over 
seven consecutive days during the study (Table 3). 
 Plasma creatinine, total cholesterol and triglycerides were 
analyzed by a photometric enzymatic method and plasma 
high-density lipoprotein (HDL) cholesterol was analyzed by 
a direct enzymatic method (Integra®, Roche, Basel, 
Switzerland). Low-density lipoprotein cholesterol was 
calculated by the Friedewald equation (Friedewald 1972). 
Troponin T was analyzed immunologically (Elecsys®, 
Roche, Basel, Switzerland). The estimated glomerular 
filtration rate (GFR) was calculated by the Cockroft-Gault 
formula and the modification of diet in renal disease 
(MDRD) formula [20,21]. 
 All blood sampling and OGTTs were performed by the 
internationally accredited laboratory of the adjacent 
university hospital (Laboratory and Pharmacy Public Utility 
of Pirkanmaa Hospital District, Tampere, Finland). 
Statistics 
 The normality of the variables was assessed graphically. 
Continuous variables are presented as means (SD) or, when 
distribution was non-parametric, as means (Q1, Q3), and 
categorical variables as counts and proportions (%). Patients 
whose glucometabolic state was not properly classified were 
excluded from the analysis. The normality of continuous 
values was tested with the D’Agostino-Pearson test. The 
correlation between variables was tested with Pearson’s 
correlation coefficient, with the exception of troponin T and 
triglycerides, which were tested with Spearman’s rho. 
Differences in baseline characteristics were compared using 
the Chi-squared test, a two-tailed Fisher’s exact test, the 
independent samples t-test and the Mann-Whitney U-test  
(SPSS 11.5, Chicago, IL, USA). The receiver operating 
characteristics (ROC) curve approach was used to evaluate 
sensitivity and specificity of PPG2h in detecting diabetes at 
each meal compared to OGTT2h. We emphasized sensitivity 
over specificity because we consider PPG2h to screen 
patients for further evaluation by OGTT. 
Ethics 
 The study protocol was approved by the Ethics 
Committee of Tampere University Hospital and conducted 
according to the Declaration of Helsinki. All patients gave 
their written, informed consent. 
RESULTS 
 According to FPG, 134 (70.9%) patients were healthy, 47 
(24.9%) had IFG, and 8 (4.2%) were diabetic. According to 
standardized OGTT, 70 (37.0%) patients had NGT, 9 (4.8%) 
had isolated increased fasting glucose, 71 (37.6%) had IGT, 
and 39 (20.6%) had diabetes. Thus, 79% (31/39) of newly 
diagnosed cases of diabetes would have been missed using 
fasting glucose only. The mean time from admission to 
hospital to PPG2h assessment was 5 (4) days (range 1-30 
days) and the corresponding time to OGTT assessment was 6 
(4) days (range 1-31 days). OGTT2h glucose did not 
decrease with increasing time from acute myocardial 
infarction (rs=0.006, p=0.934). 
 The AGT group had lower HDL cholesterol, higher body 
mass indexes and triglycerides, more frequent hypertension 
and larger waists than patients with NGT (Tables 1 and 2). 
 The mean and range of carbohydrate content of breakfast, 
lunch and dinner was 48g (43-51), 58g (47-67) and 62g (49-
83g) respectively in routine weekday hospital meals (Table 
3). PPG2h levels after each meal in the NGT, IGT and  
diabetes groups are shown in (Fig. 2). In patients with newly 
diagnosed diabetes, PPG2h levels after each meal were 
 
Fig. (1). Flowchart. PPG = postprandial glucose. 
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higher than in the IGT (p<0.001 for breakfast, p=0.014 for 
lunch and p=0.007 for dinner) and NGT groups (p<0.001 for 
breakfast, p=0.001 for lunch and p<0.001 for dinner). PPG2h 
did not differ between the NGT and IGT groups after any 
meal (p=0.075 for breakfast, p=0.586 for lunch and p=0.056 
for dinner). 
Table 1. Demographics of patients with normal (NGT) or 
abnormal glucose tolerance (AGT) in hospital. Values 
are given either as number (%) or as mean (SD). 
 
 NGT AGT P 
No. of patients 70 119  
Sex, F/M 26/44 35/84 0.272 
Age, mean (SD), y 66 (12) 65 (12) 0.656 
BMI, mean (SD), kg/m² 27 (4) 29 (5) 0.024 
Waist >88/102 cm (%)a 39 (56) 82 (69) 0.089 
Smoking (%) 33 (47) 68 (57) 0.213 
Hypertension (%) 34 (49) 84 (71) 0.011 
Family history (%) 41 (59) 71 (60) 1.000 
Previous AMI (%) 8 (11) 17 (14) 0.822 
Previous CABG (%) 4 (6) 8 (7) 0.546 
Previous Stroke/TIA (%) 6 (9) 4 (3) 0.144 
AMI = acute myocardial infarction, BMI = body mass index, CABG = coronary artery 
bypass surgery, TIA = transient ischemic attack. a Waist circumference according to the 
National Cholesterol Education Program (NCEP). 
 
 There was a significant correlation between OGTT2h and 
PPG2h after breakfast (r2=0.26, p<0.001), lunch (r2=0.13, 
p<0.001), and dinner (r2=0.16, p<0.001) (Fig. 3). Standard-
izing for age or body mass index did not change the results. 
The sensitivity of PPG2h for detecting AGT (according to 
OGTT limits) is 22%, 26%, and 38% for breakfast, lunch 
and dinner respectively. The specificity of PPG2h for 
detecting AGT is 100%, 83% and 83% for breakfast, lunch, 
and dinner respectively. The sensitivity of the single highest 
glucose value after any meal for detecting AGT was 52% 
and the specificity was 71%. Compared to morning  
 
OGTT2h, the sensitivity and specificity of PPG2h for 
detecting diabetes at the cut-off point of 5.6 mmol/l were 
78.4% and 42.1% respectively. For lunch, the sensitivity and 
specificity of PPG2h at the cut-off point 6.5 mmol/l were 
77.8% and 47.4% respectively, and for dinner, the sensitivity 
and specificity of PPG2h at 7.0 mmol/l were 76.5% and 
55.1% respectively. 
Table 2. Biochemistry of the patients with normal (NGT) or 
abnormal glucose tolerance (AGT) in hospital. 
Values are given as mean (SD or Q1,Q3). 
 
 NGT AGT P 
Hemoglobin (g/l) 132 (17) 132 (18) 0.899 
Creatinine (µmol/l) 77 (18) 82 (20) 0.111 
eGFR (CG, ml/min) 96 (31) 96 (35) 0.887 
Troponin T (µg/l) 2.2 (0.2, 2.7) 2.7 (0.3, 3.1) 0.403 
HbA1c (%) 5.4 (0.5) 5.5 (0.5) 0.623 
Cholesterol (mmol/l) 5.0 (1.4) 4.8 (1.2) 0.341 
LDL-cholesterol (mmol/l) 3.1 (1.1) 3.0 (1.1) 0.633 
HDL-cholesterol (mmol/l) 1.3 (0.4) 1.1 (0.3) 0.014 
Triglycerides (mmol/l) 1.5 (0.8, 1.6) 1.9 (1.0, 2.1) 0.012 
CG = Cockroft-Gault formula, eGFR = estimated glomerular filtration rate, HbA1c = 
Glycated hemoglobin, HDL = high-density lipoprotein, LDL = low-density lipoprotein. 
 
Table 3. Mean content of standard hospital diet. 
 
 Breakfast Lunch Dinner 
Amount (g) 564 674 607 
Energy (kcal) 383 545 483 
Carbohydrates 
(g) 48 58 62 
Protein (g) 23 30 23 
Fat (g) 11 20 15 
SFA (g) 5 6 6 
g = grams, kcal = kilocalories, SFA = saturated fatty acids. 
 
Fig. (2). Mean postprandial (± 95% CI) glucose concentration (mmol/l) two hours after each daily meal (PPG2h) in three different patient 
groups according to an oral glucose tolerance test: normal glucose tolerance (NGT), impaired fasting glucose and glucose tolerance (IFG and 
IGT), and diabetes. 
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DISCUSSION 
 This study is the first to demonstrate a correlation 
between PPG2h and OGTT2h in non-diabetic patients with 
acute myocardial infarction. PPG2h is very specific for 
categorizing glycemia but it lacks sensitivity with the 
glucose thresholds currently set for OGTT. New PPG2h 
threshold values are therefore suggested for the clinical 
decision to proceed to OGTT testing. 
 Plasma glucose is higher after OGTT compared to a 
standardized mixed meal [16]. Gastric emptying after liquid 
ingestion is more rapid than after a solid mixed meal, thus 
generating a non-physiologic inflow of glucose to the 
duodenum and portal vein circulation [22,23]. The protein 
and fat content of a meal may delay and attenuate the 
absorption of glucose and thereby produce a shallower 
pattern of PPG excursion [24,25]. In this study, the highest 
correlation between PPG2h and OGTT2h was seen after 
breakfast despite the lowest peak glucose (Fig. 2). 
 The correlation between PPG and OGTT (r2=0.13-0.26, 
p<0.001; Fig. 3) in the present study supports the findings of 
earlier studies. This is the case even though our patients were 
acutely ill and we measured PPG2h after non-standardized 
everyday hospital meals. Meier et al. [16] demonstrated a 
correlation between a standardized mixed meal and OGTT 
(r2=0.78) and self-measured home profiles and OGTT (r2 = 
0.34). Oka et al. [26] reported a loose correlation (r2=0.11) 
between a standardized rice-based meal and OGTT2h in a 
population sample. The strict testing protocol by Meier et al. 
[16] gives a high correlation between OGTT2h and PPG2h, 
but with a more practical approach at home or on the ward, 
as in the present study, the correlation is less substantial. 
More uncertainty must be accepted if patients are tested by 
the more practical method compared to a strict laboratory 
methodology when assessing postprandial glycemia. 
 In the study by Meier et al. [16], non-diabetic patients 
categorized by OGTT also had normoglycemia two hours 
after breakfast, lunch and dinner. In our NGT group, despite 
normal PPG2h after breakfast, the PPG2h after lunch and 
dinner was increased. Similarly, PPG2h was higher after 
lunch and dinner compared to breakfast in the IGT group. 
This raises the question of whether patients in the NGT 
group have a transient stress-induced disturbance in 
glycemic tolerance due to acute myocardial infarction. A 
similar pattern of stress-induced post-meal glycemic changes 
has been reported after prosthetic surgery [27]. Acute stress-
induced hyperglycemia is also supported by a study where 
61% of non-diabetic patients with acute stroke had AGT at 
discharge, but after re-investigation at three months more 
than half of them were categorized as having NGT [28]. By 
contrast, in the study by Wallander et al. [29], 93% of newly 
detected diabetic patients evaluated by OGTT during acute 
myocardial infarction at discharge still had AGT after 3 and 
12 months. This is supported by our finding that OGTT2h 
did not change within the one-month spectrum of sampling. 
Thus, there is contradictory evidence about the transitory 
nature of hyperglycemia related to acute severe illness. 
 The epidemiological data support the hypothesis that 
postprandial hyperglycemia, not FPG, is the risk factor for 
cardiovascular diseases [14]. In the Diabetes Intervention 
Study (DIS), the blood glucose after breakfast, not fasting 
blood glucose, predicted myocardial infarction and mortality 
in newly diagnosed type 2 diabetic patients [13]. 
Postprandial blood glucose has been found to be a stronger 
predictor of cardiovascular events than fasting blood glucose 
in all type 2 diabetic patients, especially in women [11]. 
 AGT defined by OGTT is suggested to be a good risk 
marker for determining cardiovascular prognosis after 
myocardial infarction [8]. In our study, there was a firm 
correlation between OGTT2h and PPG2h. Measuring PPG2h 
instead of OGTT2h could be an easier and more practical 
way to evaluate the postprandial glycemic state after 
myocardial infarction in clinical practice. All measurements 
in our study were made during routine care on the ward. The 
only exception to normal care was the PPG measurement 
three times a day. There are no studies on the role of PPG as 
a surrogate after acute myocardial infarction in the non-
diabetic population. A study comparing the PPG2h to 
OGTT2h as a cardiovascular risk marker is therefore called 
for. 
 The pathogenesis of type 2 diabetes mellitus supports the 
screening of postprandial hyperglycemia instead of fasting 
glucose or HbA1c in the non-diabetic population [2]. Only 
after the postprandial glycemic control is lost will the 
deterioration of fasting hyperglycemia ensue [3]. Initial 
decrease of postprandial insulin release and also insulin 
resistance have been proposed to be genetically transmitted 
risk factors predisposing individuals to type 2 diabetes [4]. In 
patients with IGT, decreasing PPG with acarbose was 
 
Fig. (3). Correlation between two-hour oral glucose tolerance test (OGTT2h) and two-hour postprandial glucose (PPG2h) at each daily meal 
in non-diabetic patients with acute myocardial infarction. Dashed lines represent glucose cut-off values of 7.8 and 11.1 mmol/l. 
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associated with a lower incidence of cardiovascular events in 
the STOP-NIDDM Study [12]. 
 Norhammar et al. showed that OGTT can predict 
cardiovascular events in patients with myocardial infarction. 
We adopted a similar study design to compare PPG2h to 
OGTT2h. Despite similar inclusion criteria and the very 
similar population and way of living in Sweden and Finland, 
these two studies have some differences. First, fasting 
glucose criteria for diagnosing diabetes differ between the 
World Health Organization and American Diabetic 
Association. Second, whole blood glucose levels are 12% 
lower than plasma glucose. Plasma sampling in our study 
should increase detection of IGT and diabetes. Third, 
compared to the patients of Norhammar et al. [30] our 
patients were older, more obese, and had more a frequent 
history of hypertension, which would be expected to increase 
the number of AGT patients. Instead, compared to the study 
population of Norhammar et al. [30], there were fewer new 
diabetic patients (21% vs. 33%) but hardly any difference in 
the number of AGT patients (63% vs. 68%). The best 
explanation for these differences is the program for the 
prevention of type 2 diabetes in Finland, which was 
conducted during 2003-2008 [31]. 
 There are a number of limitations in our study. First, 
during our study a great majority of patients left hospital 
before being able to participate in the study. They were 
either not given permission to eat regular meals before 
transfer to another unit or they did not have time for OGTT. 
We cannot exclude the possibility that the study population 
is biased to include more sick and older people and 
complicated cases. Second, we did not record what 
proportion of food was eaten, which may increase the 
number of false negative results. Third, we did not 
standardize meal size or the content of carbohydrates, protein 
or fat. Fourth, medication was recorded only at discharge. 
However, the effect of medications on the OGTT and PPG2h 
measurements are similar. 
 On the other hand, the strength of this study, is a practical 
everyday approach in evaluating postprandial glycemia. 
CONCLUSION 
 PPG2h is a quick, practical, simple and easy estimate for 
evaluating postprandial glycemia after myocardial infarction 
in clinical practice. Because the PPG2h value is lower than 
OGTT2h, the sensitivity of PPG2h in detecting IGT and 
diabetes is low with the current cut-off values designed for 
OGTT. New cut-off values for PPG2h are therefore 
suggested. The new values could be used to find patients in 
whom further testing by OGTT is not needed. 
ABBREVIATIONS 
AGT = Abnormal glucose tolerance 
FPG = Fasting plasma glucose 
GFR = Glomerular filtration rate 
HbA1c = Hemoglobin A1c 
IGT = Impaired glucose tolerance 
NGT = Normal glucose tolerance 
OGTT = Oral glucose tolerance test 
OGTT2h = Two-hour oral glucose tolerance test 
PPG = Postprandial glucose 
PPG2h = Two-hour postprandial glucose 
ROC = Receiver operating characteristic 
SD = Standard deviation 
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